| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairman, President &CEO | Director
3 companies
Mahoney Michael F is a Chairman, President &CEO at BOSTON SCIENTIFIC CORP with holdings across 3 companies. Recent SEC Form 4 filings include 2 buys and 12 sells.
Estimated insider holdings value: $12.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2025 | BSX Boston Scientific Corp | Chairman, President &CEO | Sale+OE | 164,443 | $103.69 | $17,051,135.67 | -5.1% | +2.4% | - | |
| May 1, 2025 | BSX Boston Scientific Corp | Chairman, President &CEO | Sale+OE | 164,443 | $102.48 | $16,851,973.70 | -4.9% | +3.5% | -45.2% | |
| Apr 1, 2025 | BSX Boston Scientific Corp | Chairman, President &CEO | Sale+OE | 164,442 | $100.01 | $16,445,071.54 | -9.3% | +6.1% | -38.8% | |
| Feb 18, 2025 | CVS Cvs Health Corp | Director | Buy | 30,000 | $66.70 | $2,001,000.00 | +320.6% | -4.3% | +18.6% | |
| Nov 5, 2024 | BSX Boston Scientific Corp | Chairman, President &CEO | Sale+OE | 162,778 | $84.75 | $13,794,850.92 | -4.8% | +20.5% | +15.6% | |
| Oct 7, 2024 | BSX Boston Scientific Corp | Chairman, President &CEO | Sale+OE | 162,777 | $84.63 | $13,775,791.62 | -4.8% | +8.2% | +13.6% | |
| Sep 5, 2024 | BSX Boston Scientific Corp | Chairman, President &CEO | Sale+OE | 162,777 | $81.17 | $13,212,543.98 | -9.1% | +11.6% | +31.8% | |
| May 2, 2024 | CVS Cvs Health Corp | Director | Buy | 9,181 | $54.49 | $500,293.81 | +5,246% | +9.4% | +22.3% | |
| Nov 6, 2023 | BSX Boston Scientific Corp | Chairman, President &CEO | Sale+OE | 113,356 | $52.51 | $5,951,983.49 | -7.0% | +22.1% | +62.0% | |
| Oct 9, 2023 | BSX Boston Scientific Corp | Chairman, President &CEO | Sale+OE | 113,355 | $52.09 | $5,904,480.58 | -7.0% | +11.5% | +63.8% |